IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-18
DOI
10.1038/srep25937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome
- (2016) Roshell Muir et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The IL-17A/IL-17RA axis in pulmonary defence and immunopathology
- (2016) Nicola Ivan Lorè et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
- (2016) Cristina Cigana et al. Scientific Reports
- Interleukin-17 and innate immunity in infections and chronic inflammation
- (2015) Natasa Isailovic et al. JOURNAL OF AUTOIMMUNITY
- Targeting the IL-17–TH17 pathway
- (2015) Hilary S. Bartlett et al. NATURE REVIEWS DRUG DISCOVERY
- Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense
- (2014) Jeremy P. McAleer et al. IMMUNOLOGICAL REVIEWS
- A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
- (2014) M.W. Konstan et al. Journal of Cystic Fibrosis
- Chronic obstructive pulmonary disease (COPD): Evaluation from clinical, immunological and bacterial pathogenesis perspectives
- (2014) Daniel J. Hassett et al. JOURNAL OF MICROBIOLOGY
- Pseudomonas aeruginosaisolates in severe chronic obstructive pulmonary disease: characterization and risk factors
- (2014) Miguel Gallego et al. BMC Pulmonary Medicine
- Interleukin-17 and Cystic Fibrosis Lung Disease
- (2013) Malcolm Brodlie et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Th17- and Th2-skewed Cytokine Profile in Cystic Fibrosis Lungs Represents a Potential Risk Factor forPseudomonas aeruginosaInfection
- (2013) Kerstin Tiringer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of Myeloid Cell Subsets in Murine Lungs Using Flow Cytometry
- (2013) Rinat Zaynagetdinov et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs
- (2013) Gerd Döring et al. Journal of Cystic Fibrosis
- T Cell-Derived IL-17 Mediates Epithelial Changes in the Airway and Drives Pulmonary Neutrophilia
- (2013) L. K. Fogli et al. JOURNAL OF IMMUNOLOGY
- IL-17 in lung disease: friend or foe?
- (2013) Hui-Leng Tan et al. THORAX
- The responses of γδ T-cells against acutePseudomonas aeruginosapulmonary infection in mice via interleukin-17
- (2013) Jialin Liu et al. Pathogens and Disease
- IL-17 cytokines in immunity and inflammation
- (2013) Wei Jin et al. Emerging Microbes & Infections
- Cystic fibrosis: a mucosal immunodeficiency syndrome
- (2012) Taylor Sitarik Cohen et al. NATURE MEDICINE
- IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction
- (2012) Makoto Kudo et al. NATURE MEDICINE
- Targeting IL-17 and TH17 cells in chronic inflammation
- (2012) Pierre Miossec et al. NATURE REVIEWS DRUG DISCOVERY
- Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts
- (2012) Nicola Ivan Lorè et al. PLoS One
- Marking and Quantifying IL-17A-Producing Cells In Vivo
- (2012) April E. Price et al. PLoS One
- Disease Tolerance as a Defense Strategy
- (2012) R. Medzhitov et al. SCIENCE
- IL-17–Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease
- (2011) Sumanta Mukherjee et al. AMERICAN JOURNAL OF PATHOLOGY
- The Th17 Pathway in Cystic Fibrosis Lung Disease
- (2011) Hui-Leng Tan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-17 in Cystic Fibrosis: More Than Just Th17 Cells
- (2011) Patricia J. Dubin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pravastatin Reduces Marfan Aortic Dilation
- (2011) D. McLoughlin et al. CIRCULATION
- Interleukin-23-Mediated Inflammation in Pseudomonas aeruginosa Pulmonary Infection
- (2011) Patricia J. Dubin et al. INFECTION AND IMMUNITY
- Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF- 1-Dependent and -Independent Mechanisms
- (2011) S. Mi et al. JOURNAL OF IMMUNOLOGY
- Role of IL-17A on Resolution of Pulmonary C. neoformans Infection
- (2011) Karen L. Wozniak et al. PLoS One
- IL-17 family member cytokines: Regulation and function in innate immunity
- (2010) Joseph M. Reynolds et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Murine models of acute and chronic lung infection with cystic fibrosis pathogens
- (2010) Alessandra Bragonzi INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence
- (2009) Alessandra Bragonzi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Interleukin-17 as a drug target in human disease
- (2009) Stefan Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- From cells to organs: building polarized tissue
- (2008) David M. Bryant et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Decomposing health: tolerance and resistance to parasites in animals
- (2008) L. Raberg et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started